| Bioactivity | IONIS-DNM2-2.5Rx (DYM101) is an antisense agent targeting dynamin 2. IONIS-DNM2-2.5Rx has the potential for the research of centronuclear myopathy (CNM)[1]. |
| Name | IONIS-DNM2-2.5Rx |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure. |